Biotricity's ECG device, Biotres Pro, drives company towards breakeven with high demand and revenue growth.

Biotricity's medical diagnostic product, Biotres Pro, is experiencing high demand, driving the company towards breakeven. The 3-channel patch-like ECG device boosts subscription prices by over 32%, increasing revenue from existing customers by 10% by fiscal 2025. Biotres Pro's popularity also attracts new customers, with the initial production run sold out and pre-orders for the next shipment by May.

April 26, 2024
4 Articles